-
2023-503735-17-00
Hepatic impairment. 3 2023-10-05
-
2023-503542-31-00
Healthy volunteer trial 9 2023-09-29
-
2023-505180-36-00
Impaired Hepatic Function
The study will enroll as fol 3 2023-09-21
-
2023-505411-20-00
There is no medical condition being investigated. This 1 2023-09-20
-
2023-507226-16-00
Healthy volunteers 2 2023-09-13
-
2023-506416-41-00
No medical condition 2 2023-09-11
-
2023-506559-10-00
Healthy volunteers 2 2023-09-07
-
2023-504258-36-00
No medical condition 2 2023-09-01
-
2023-503647-34-00
Healthy volunteers 2 2023-08-31
-
2023-504281-34-00
Adult patients with advanced solid tumors 3 2023-08-22
-
2023-504903-10-00
No medical condition. 2 2023-08-16
-
2022-503047-17-00
Healthy 3 2023-08-10
-
2023-504260-42-00
No medical condition 3 2023-08-08
-
2023-504052-99-00
Musculoskeletal and connective tissue disorders, Dysmen 2 2023-07-31
-
2022-502424-43-00
Healthy volunteer trial 1 2023-07-25
-
2023-505692-72-00
Healthy volunteers 2 2023-07-18
-
2023-503226-39-00
Extramembranous glomerulonephritis 4 2023-07-18
-
2023-504492-24-00
healthy 3 2023-07-12
-
2023-504007-91-00
Impaired Hepatic Function
The study will enroll as foll 3 2023-07-06
-
2023-504523-83-00
No medical condition 2 2023-06-29
-
2023-504527-40-00
No medical condition 2 2023-06-29
-
2024-513650-30-00
Allograft vascular thrombosis 5 2023-06-28
-
2023-504987-40-00
Healthy volunteers 2 2023-06-26
-
2023-503528-25-00
There is no medical condition being investigated. This 3 2023-06-09